Epigenetic regulation of osteogenic differentiation of mesenchymal stem cells

Current Stem Cell Research and Therapy

Volumn 11, Issue 3, 2016, Pages 235-246

  Fu, Gang ^a   Ren, Aishu ^a   Qiu, Yu ^a   Zhang, Yi ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

DNA methylation; Epigenetic; Histone modification; Mesenchymal stem cells; MicroRNA; Osteogenic differentiation

Indexed keywords

DNA METHYLTRANSFERASE; HISTONE H3; HISTONE H4; MICRORNA; MICRORNA 100; MICRORNA 124; MICRORNA 124A; MICRORNA 135B; MICRORNA 138; MICRORNA 142; MICRORNA 146A; MICRORNA 181A; MICRORNA 194; MICRORNA 196A; MICRORNA 204; MICRORNA 20A; MICRORNA 21; MICRORNA 218; MICRORNA 22; MICRORNA 27; MICRORNA 29A; MICRORNA 31; MICRORNA 322; MICRORNA 335; MICRORNA 346; MICRORNA 34A; MICRORNA 637; MICRORNA 96; NOTCH RECEPTOR; SONIC HEDGEHOG PROTEIN; UNCLASSIFIED DRUG; HISTONE;

BONE DEFECT; BONE DEVELOPMENT; BONE REGENERATION; CATALYSIS; CELL DIFFERENTIATION; CELL FATE; DEACETYLATION; DNA METHYLATION; EMBRYO DEVELOPMENT; EPIGENETICS; HISTONE ACETYLATION; HISTONE METHYLATION; HUMAN; MESENCHYMAL STEM CELL; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; TISSUE DIFFERENTIATION; WNT SIGNALING PATHWAY; ACETYLATION; BONE MARROW CELL; CYTOLOGY; GENETIC EPIGENESIS; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY;

ACETYLATION; BONE MARROW CELLS; DNA METHYLATION; EPIGENESIS, GENETIC; HISTONES; HUMANS; MESENCHYMAL STROMAL CELLS; MICRORNAS; OSTEOBLASTS; OSTEOGENESIS;

EID: 84961692298     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574888X10666150528153313     Document Type: Review

References (139)

1. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284(5411): 143-7.
2. Prockop DJ, Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276(5309): 71-4.
3. Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976; 4(5): 267-74.
4. Mauney JR, Nguyen T, Gillen K, et al. Engineering adipose-like tissue in vitro and in vivo utilizing human bone marrow and adipose-derived mesenchymal stem cells with silk fibroin 3D scaffolds. Biomaterials 2007; 28(35): 5280-90.
5. Jankowski RJ, Deasy BM, Huard J. Muscle-derived stem cells. Gene Ther 2002; 9(10): 642-7.
6. Noth U, Osyczka AM, Tuli R, et al. Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res 2002; 20(5): 1060-9.
7. Fukumoto T, Sperling JW, Sanyal A, et al. Combined effects of insulin-like growth factor-1 and transforming growth factor-beta1 on periosteal mesenchymal cells during chondrogenesis in vitro. Osteoarthritis Cartilage 2003; 11(1): 55-64.
8. Fan X, Liu T, Liu Y, et al. Optimization of primary culture condition for mesenchymal stem cells derived from umbilical cord blood with factorial design. Biotechnol Prog 2009; 25(2): 499-507.
9. Tsai MS, Lee JL, Chang YJ, et al. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 2004; 19(6): 1450-6.
10. Seo BM, Miura M, Gronthos S, et al. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 2004; 364(9429): 149-55.
11. Gronthos S, Brahim J, Li W, et al. Stem cell properties of human dental pulp stem cells. J Dent Res 2002; 81(8): 531-5.
12. Kassem M, Mesenchymal stem cells: biological characteristics and potential clinical applications. Cloning Stem Cells 2004; 6(4): 369-74.
13. Horwitz EM, Prockop DJ, Fitzpatrick LA, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999; 5(3): 309-13.
14. Caplan AI, Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007; 213(2): 341-7.
15. Egger G, Liang G, Aparicio A, et al. Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004; 429(6990): 457-63.
16. Vincent A, Van Seuningen I. Epigenetics, stem cells and epithelial cell fate. Differentiation 2009; 78(2-3): 99-107.
17. Robertson KD, Wolffe AP. DNA methylation in health and disease. Nat Rev Genet 2000; 1(1): 11-9.
18. Bartel DP, MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116(2): 281-97.
19. Dai B, Rasmussen TP. Global epiproteomic signatures distinguish embryonic stem cells from differentiated cells. Stem Cells 2007; 25(10): 2567-74.
20. Lian JB, Stein GS, Javed A, et al. Networks and hubs for the transcriptional control of osteoblastogenesis. Rev Endocr Metab Disord 2006; 7(1-2): 1-16.
21. Karsenty G, Kronenberg HM, Settembre C. Genetic control of bone formation. Annu Rev Cell Dev Biol 2009; 25: 629-48.
22. Phimphilai M, Zhao Z, Boules H, et al. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype. J Bone Miner Res 2006; 21(4): 637-46.
23. Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors 2004; 22(4): 233-41.
24. Jenuwein T, Allis CD. Translating the histone code. Science 2001; 293(5532): 1074-80.
25. Shi Y, Histone lysine demethylases: emerging roles in development, physiology and disease. Nat Rev Genet 2007; 8(11): 829-33.
26. Coelho MJ, Fernandes MH. Human bone cell cultures in biocompatibility testing. Part II: effect of ascorbic acid, betaglycerophosphate and dexamethasone on osteoblastic differentiation. Biomaterials 2000; 21(11): 1095-102.
27. Porter RM, Huckle WR, Goldstein AS, Effect of dexamethasone withdrawal on osteoblastic differentiation of bone marrow stromal cells. J Cell Biochem 2003; 90(1): 13-22.
28. Choi KM, Seo YK, Yoon HH, et al. Effect of ascorbic acid on bone marrow-derived mesenchymal stem cell proliferation and differentiation. J Biosci Bioeng 2008; 105(6): 586-94.
29. Chung CH, Golub EE, Forbes E, et al. Mechanism of action of beta-glycerophosphate on bone cell mineralization. Calcif Tissue Int 1992; 51(4): 305-11.
30. Rickard DJ, Kazhdan I, Leboy PS. Importance of 1,25-dihydroxyvitamin D3 and the nonadherent cells of marrow for osteoblast differentiation from rat marrow stromal cells. Bone 1995; 16(6): 671-8.
31. Holzer G, Einhorn TA, Majeska RJ. Estrogen regulation of growth and alkaline phosphatase expression by cultured human bone marrow stromal cells. J Orthop Res 2002; 20(2): 281-8.
32. Su N, Jin M, Chen L. Role of FGF/FGFR signaling in skeletal development and homeostasis: learning from mouse models. Bone Res 2014; 2: 14003.
33. Wang Y, Bikle DD, Chang W. Autocrine and Paracrine Actions of IGF-I Signaling in Skeletal Development. Bone Res 2013; 1(3): 249-59.
34. Zhou H, Cooper MS, Seibel MJ. Endogenous Glucocorticoids and Bone. Bone Res 2013; 1(2): 107-19.
35. Lin GL, Hankenson KD. Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation. J Cell Biochem 2011; 112(12): 3491-501.
36. Ducy P, Zhang R, Geoffroy V, et al. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997; 89(5): 747-54.
37. Nakashima K, Zhou X, Kunkel G, et al. The novel zinc fingercontaining transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002; 108(1): 17-29.
38. Acampora D, Merlo GR, Paleari L, et al. Craniofacial, vestibular and bone defects in mice lacking the Distal-less-related gene Dlx5. Development 1999; 126(17): 3795-809.
39. Cheng SL, Shao JS, Charlton-Kachigian N, et al. MSX2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors. J Biol Chem 2003; 278(46): 45969-77.
40. Hassan MQ, Tare R, Lee SH, et al. HOXA10 controls osteoblastogenesis by directly activating bone regulatory and phenotypic genes. Mol Cell Biol 2007; 27(9): 3337-52.
41. Gori F, Thomas T, Hicok KC, et al. Differentiation of human marrow stromal precursor cells: bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation. J Bone Miner Res 1999; 14(9): 1522-35.
42. St-Jacques B, Hammerschmidt M, McMahon AP. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev 1999; 13(16): 2072-86.
43. Chiang C, Litingtung Y, Lee E, et al. Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature 1996; 383(6599): 407-13.
44. Zamurovic N, Cappellen D, Rohner D, et al. Coordinated activation of notch, Wnt, and transforming growth factor-beta signaling pathways in bone morphogenic protein 2-induced osteogenesis. Notch target gene Hey1 inhibits mineralization and Runx2 transcriptional activity. J Biol Chem 2004; 279(36): 37704-15.
45. Bennett CN, Longo KA, Wright WS, et al. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci USA 2005; 102(9): 3324-9.
46. Boland GM, Perkins G, Hall DJ, et al. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem 2004; 93(6): 1210-30.
47. Aranda P, Agirre X, Ballestar E, et al. Epigenetic signatures associated with different levels of differentiation potential in human stem cells. PLoS One 2009; 4(11): e7809.
48. Bird A, DNA methylation patterns and epigenetic memory. Genes Dev 2002; 16(1): 6-21.
49. Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J Mol Biol 1987; 196(2): 261-82.
50. Holliday R, Pugh JE. DNA modification mechanisms and gene activity during development. Science 1975; 187(4173): 226-32.
51. Riggs AD, X inactivation, differentiation, and DNA methylation. Cytogenet Cell Genet 1975; 14(1): 9-25.
52. Bibikova M, Chudin E, Wu B, et al. Human embryonic stem cells have a unique epigenetic signature. Genome Res 2006; 16(9): 1075-83.
53. Meissner A, Mikkelsen TS, Gu H, et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 2008; 454(7205): 766-70.
54. Turek-Plewa J, Jagodzinski PP. The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell Mol Biol Lett 2005; 10(4): 631-47.
55. Okano M, Bell DW, Haber DA, et al. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999; 99(3): 247-57.
56. Kouzarides T, Chromatin modifications and their function. Cell 2007; 128(4): 693-705.
57. Collas P, Noer A, Sorensen AL. Epigenetic Basis for the Differentiation Potential of Mesenchymal and Embryonic Stem Cells. Transfus Med Hemother 2008; 35(3): 205-215.
58. Sterner DE, Berger SL. Acetylation of histones and transcriptionrelated factors. Microbiol Mol Biol Rev 2000; 64(2): 435-59.
59. Yang XJ, Seto E. HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene 2007; 26(37): 5310-8.
60. Bedford MT, Clarke SG. Protein arginine methylation in mammals: who, what, and why. Mol Cell 2009; 33(1): 1-13.
61. Ng SS, Yue WW, Oppermann U, et al. Dynamic protein methylation in chromatin biology. Cell Mol Life Sci 2009; 66(3): 407-22.
62. Schwartz YB, Pirrotta V. Polycomb silencing mechanisms and the management of genomic programmes. Nat Rev Genet 2007; 8(1): 9-22.
63. Simon JA, Kingston RE. Mechanisms of polycomb gene silencing: knowns and unknowns. Nat Rev Mol Cell Biol 2009; 10(10): 697-708.
64. Agger K, Cloos PA, Christensen J, et al. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 2007; 449(7163): 731-4.
65. De Santa F, Totaro MG, Prosperini E, et al. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 2007; 130(6): 1083-94.
66. Lan F, Bayliss PE, Rinn JL, et al. A histone H3 lysine 27 demethylase regulates animal posterior development. Nature 2007; 449(7163): 689-94.
67. Azuara V, Perry P, Sauer S, et al. Chromatin signatures of pluripotent cell lines. Nat Cell Biol 2006; 8(5): 532-8.
68. Bernstein BE, Kamal M, Lindblad-Toh K, et al. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 2005; 120(2): 169-81.
69. Copeland RA, Solomon ME, Richon VM. Protein methyltransferases as a target class for drug discovery. Nat Rev Drug Discov 2009; 8(9): 724-32.
70. Shi Y, Lan F, Matson C, et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004; 119(7): 941-53.
71. Li G, Fu N, Yang X, et al. Mechanical compressive force inhibits adipogenesis of adipose stem cells. Cell Prolif 2013; 46(5): 586-94.
72. Huang J, Zhang SY, Gao YM, et al. MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets. Cell Prolif 2014; 47(4): 277-86.
73. Li M, Yu M, Liu C, et al. miR-34c works downstream of p53 leading to dairy goat male germline stem-cell (mGSCs) apoptosis. Cell Prolif 2013; 46(2): 223-31.
74. Kobayashi T, Lu J, Cobb BS, et al. Dicer-dependent pathways regulate chondrocyte proliferation and differentiation. Proc Natl Acad Sci USA 2008; 105(6): 1949-54.
75. Wei X, Li G, Yang X, et al. Effects of bone morphogenetic protein-4 (BMP-4) on adipocyte differentiation from mouse adiposederived stem cells. Cell Prolif 2013; 46(4): 416-24.
76. Sorensen AL, Timoskainen S, West FD, et al. Lineage-specific promoter DNA methylation patterns segregate adult progenitor cell types. Stem Cells Dev 2010; 19(8): 1257-66.
77. Yannarelli G, Pacienza N, Cuniberti L, et al. Brief report: The potential role of epigenetics on multipotent cell differentiation capacity of mesenchymal stromal cells. Stem Cells 2013; 31(1): 215-20.
78. Sorensen AL, Jacobsen BM, Reiner AH, et al. Promoter DNA methylation patterns of differentiated cells are largely programmed at the progenitor stage. Mol Biol Cell 2010; 21(12): 2066-77.
79. Villagra A, Gutierrez J, Paredes R, et al. Reduced CpG methylation is associated with transcriptional activation of the bone-specific rat osteocalcin gene in osteoblasts. J Cell Biochem 2002; 85(1): 112-22.
80. Fu N, Yang X, Ba K, et al. Low-intensity pulsed ultrasound induced enhanced adipogenesis of adipose-derived stem cells. Cell Prolif 2013; 46(3): 312-9.
81. Hu M, Yeh R, Lien M, et al. Dynamic Fluid Flow Mechanical Stimulation Modulates Bone Marrow Mesenchymal Stem Cells. Bone Res 2013; 1(1): 98-104.
82. Grottkau BE, Yang X, Zhang L, et al. Comparison of Effects of Mechanical Stretching on Osteogenic Potential of ASCs and BMSCs. Bone Res 2013; 1(3): 282-290.
83. Arnsdorf EJ, Tummala P, Castillo AB, et al. The epigenetic mechanism of mechanically induced osteogenic differentiation. J Biomech 2010; 43(15): 2881-6.
84. Tarfiei G, Noruzinia M, Soleimani M, et al. ROR2 Promoter Methylation Change in Osteoblastic Differentiation of Mesenchymal Stem Cells. Cell J 2011; 13(1): 11-5.
85. Dansranjavin T, Krehl S, Mueller T, et al. The role of promoter CpG methylation in the epigenetic control of stem cell related genes during differentiation. Cell Cycle 2009; 8(6): 916-24.
86. Negishi M, Saraya A, Miyagi S, et al. Bmi1 cooperates with Dnmt1-associated protein 1 in gene silencing. Biochem Biophys Res Commun 2007; 353(4): 992-8.
87. Hsiao SH, Lee KD, Hsu CC, et al. DNA methylation of the Trip10 promoter accelerates mesenchymal stem cell lineage determination. Biochem Biophys Res Commun 2010; 400(3): 305-12.
88. Shen J, Hovhannisyan H, Lian JB, et al. Transcriptional induction of the osteocalcin gene during osteoblast differentiation involves acetylation of histones h3 and h4. Mol Endocrinol 2003; 17(4): 743-56.
89. Wu L, Cai X, Dong H, et al. Serum regulates adipogenesis of mesenchymal stem cells via MEK/ERK-dependent PPARgamma expression and phosphorylation. J Cell Mol Med 2010; 14(4): 922-32.
90. Li Z, Liu C, Xie Z, et al. Epigenetic dysregulation in mesenchymal stem cell aging and spontaneous differentiation. PLoS One 2011; 6(6): e20526.
91. Tan J, Lu J, Huang W, et al. Genome-wide analysis of histone H3 lysine9 modifications in human mesenchymal stem cell osteogenic differentiation. PLoS One 2009; 4(8): e6792.
92. Ye L, Fan Z, Yu B, et al. Histone demethylases KDM4B and KDM6B promotes osteogenic differentiation of human MSCs. Cell Stem Cell 2012; 11(1): 50-61.
93. Xu J, Yu B, Hong C, et al. KDM6B epigenetically regulates odontogenic differentiation of dental mesenchymal stem cells. Int J Oral Sci 2013; 5(4): 200-5.
94. Wei Y, Chen YH, Li LY, et al. CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells. Nat Cell Biol 2011; 13(1): 87-94.
95. Hemming S, Cakouros D, Isenmann S, et al. EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specification. Stem Cells 2014; 32(3): 802-15.
96. Ng D, Thakker N, Corcoran CM, et al. Oculofaciocardiodental and Lenz microphthalmia syndromes result from distinct classes of mutations in BCOR. Nat Genet 2004; 36(4): 411-6.
97. Oberoi S, Winder AE, Johnston J, et al. Case reports of oculofaciocardiodental syndrome with unusual dental findings. Am J Med Genet A 2005; 136(3): 275-7.
98. Horn D, Chyrek M, Kleier S, et al. Novel mutations in BCOR in three patients with oculo-facio-cardio-dental syndrome, but none in Lenz microphthalmia syndrome. Eur J Hum Genet 2005; 13(5): 563-9.
99. Fan Z, Yamaza T, Lee JS, et al. BCOR regulates mesenchymal stem cell function by epigenetic mechanisms. Nat Cell Biol 2009; 11(8): 1002-9.
100. Zhang JF, Fu WM, He ML, et al. MiRNA-20a promotes osteogenic differentiation of human mesenchymal stem cells by co-regulating BMP signaling. RNA Biol 2011; 8(5): 829-38.
101. Kapinas K, Kessler C, Ricks T, et al. miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop. J Biol Chem 2010; 285(33): 25221-31.
102. Wang T, Xu Z. miR-27 promotes osteoblast differentiation by modulating Wnt signaling. Biochem Biophys Res Commun 2010; 402(2): 186-9.
103. Hu W, Ye Y, Zhang W, et al. miR1423p promotes osteoblast differentiation by modulating Wnt signaling. Mol Med Rep 2013; 7(2): 689-93.
104. Zhang WB, Zhong WJ, Wang L. A signal-amplification circuit between miR-218 and Wnt/beta-catenin signal promotes human adipose tissue-derived stem cells osteogenic differentiation. Bone 2014; 58: 59-66.
105. Wang Q, Cai J, Cai XH, et al. miR-346 regulates osteogenic differentiation of human bone marrow-derived mesenchymal stem cells by targeting the Wnt/beta-catenin pathway. PLoS One 2013; 8(9): e72266.
106. Huang S, Wang S, Bian C, et al. Upregulation of miR-22 promotes osteogenic differentiation and inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells by repressing HDAC6 protein expression. Stem Cells Dev 2012; 21(13): 2531-40.
107. Gamez B, Rodriguez-Carballo E, Bartrons R, et al. MicroRNA-322 (miR-322) and its target protein Tob2 modulate Osterix (Osx) mRNA stability. J Biol Chem 2013; 288(20): 14264-75.
108. Yang N, Wang G, Hu C, et al. Tumor necrosis factor alpha suppresses the mesenchymal stem cell osteogenesis promoter miR-21 in estrogen deficiency-induced osteoporosis. J Bone Miner Res 2013; 28(3): 559-73.
109. Trohatou O, Zagoura D, Bitsika V, et al. Sox2 suppression by miR-21 governs human mesenchymal stem cell properties. Stem Cells Transl Med 2014; 3(1): 54-68.
110. Yang M, Pan Y, Zhou Y. miR-96 promotes osteogenic differentiation by suppressing HBEGF-EGFR signaling in osteoblastic cells. FEBS Lett 2014; 588(24): 4761-8.
111. Jeong BC, Kang IH, Hwang YC, et al. MicroRNA-194 reciprocally stimulates osteogenesis and inhibits adipogenesis via regulating COUP-TFII expression. Cell Death Dis 2014; 5: e1532.
112. Kim YJ, Bae SW, Yu SS, et al. miR-196a regulates proliferation and osteogenic differentiation in mesenchymal stem cells derived from human adipose tissue. J Bone Miner Res 2009; 24(5): 816-25.
113. Qadir AS, Um S, Lee H, et al. miR-124 Negatively Regulates Osteogenic Differentiation and In Vivo Bone Formation of Mesenchymal Stem Cells. J Cell Biochem 2014.
114. Xie Q, Wang Z, Bi X, et al. Effects of miR-31 on the osteogenesis of human mesenchymal stem cells. Biochem Biophys Res Commun 2014; 446(1): 98-104.
115. Deng Y, Wu S, Zhou H, et al. Effects of a miR-31, Runx2, and Satb2 regulatory loop on the osteogenic differentiation of bone mesenchymal stem cells. Stem Cells Dev 2013; 22(16): 2278-86.
116. Baglio SR, Devescovi V, Granchi D, et al. MicroRNA expression profiling of human bone marrow mesenchymal stem cells during osteogenic differentiation reveals Osterix regulation by miR-31. Gene 2013; 527(1): 321-31.
117. Xu S, Cecilia Santini G, De Veirman K, et al. Upregulation of miR-135b is involved in the impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients. PLoS One 2013; 8(11): e79752.
118. Wu T, Zhou H, Hong Y, et al. miR-30 family members negatively regulate osteoblast differentiation. J Biol Chem 2012; 287(10): 7503-11.
119. Li H, Li T, Wang S, et al. miR-17-5p and miR-106a are involved in the balance between osteogenic and adipogenic differentiation of adipose-derived mesenchymal stem cells. Stem Cell Res 2013; 10(3): 313-24.
120. Liao L, Yang X, Su X, et al. Redundant miR-3077-5p and miR-705 mediate the shift of mesenchymal stem cell lineage commitment to adipocyte in osteoporosis bone marrow. Cell Death Dis 2013; 4: e600.
121. Okamoto H, Matsumi Y, Hoshikawa Y, et al. Involvement of microRNAs in regulation of osteoblastic differentiation in mouse induced pluripotent stem cells. PLoS One 2012; 7(8): e43800.
122. Chen L, Holmstrom K, Qiu W, et al. MicroRNA-34a inhibits osteoblast differentiation and in vivo bone formation of human stromal stem cells. Stem Cells 2014: 32(4): 902-12.
123. Zeng Y, Qu X, Li H, et al. MicroRNA-100 regulates osteogenic differentiation of human adipose-derived mesenchymal stem cells by targeting BMPR2. FEBS Lett 2012; 586(16): 2375-81.
124. Chen S, Yang L, Jie Q, et al. MicroRNA125b suppresses the proliferation and osteogenic differentiation of human bone marrowderived mesenchymal stem cells. Mol Med Rep 2014; 9(5): 1820-6.
125. Huang K, Fu J, Zhou W, et al. MicroRNA-125b regulates osteogenic differentiation of mesenchymal stem cells by targeting Cbfbeta in vitro. Biochimie 2014; 102: 47-55.
126. Eskildsen T, Taipaleenmaki H, Stenvang J, et al. MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc Natl Acad Sci USA 2011; 108(15): 6139-44.
127. Hwang S, Park SK, Lee HY, et al. miR-140-5p suppresses BMP2-mediated osteogenesis in undifferentiated human mesenchymal stem cells. FEBS Lett 2014; 588(17): 2957-63.
128. Huszar JM and Payne CJ, MIR146A inhibits JMJD3 expression and osteogenic differentiation in human mesenchymal stem cells. FEBS Lett 2014; 588(9): 1850-6.
129. Huang J, Zhao L, Xing L, et al. MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells 2010; 28(2): 357-64.
130. Tome M, Lopez-Romero P, Albo C, et al. miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells. Cell Death Differ 2011; 18(6): 985-95.
131. Zhang JF, Fu WM, He ML, et al. MiR-637 maintains the balance between adipocytes and osteoblasts by directly targeting Osterix. Mol Biol Cell 2011; 22(21): 3955-61.
132. Kolf CM, Cho E, Tuan RS. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 2007; 9(1): 204.
133. Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views. Stem Cells 2007; 25(11): 2896-902.
134. Undale AH, Westendorf JJ, Yaszemski MJ, et al. Mesenchymal stem cells for bone repair and metabolic bone diseases. Mayo Clin Proc 2009; 84(10): 893-902.
135. Chen TH, Chen WM, Hsu KH, et al. Sodium butyrate activates ERK to regulate differentiation of mesenchymal stem cells. Biochem Biophys Res Commun 2007; 355(4): 913-8.
136. Xu S, De Veirman K, Evans H, et al. Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo. Acta Pharmacol Sin 2013; 34(5): 699-709.
137. Hu N, Wang C, Liang X, et al. Inhibition of histone deacetylases potentiates BMP9-induced osteogenic signaling in mouse mesenchymal stem cells. Cell Physiol Biochem 2013; 32(2): 486-98.
138. Yan J, Zhang C, Zhao Y, et al. Non-viral oligonucleotide antimiR-138 delivery to mesenchymal stem cell sheets and the effect on osteogenesis. Biomaterials 2014; 35(27): 7734-49.
139. Deng Y, Zhou H, Gu P, et al. Repair of canine medial orbital bone defects with miR-31-modified bone marrow mesenchymal stem cells. Invest Ophthalmol Vis Sci 2014; 55(9): 6016-23.